Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Deibel, Scott H.a; b; * | Young, Bryanta | Mohajerani, Majid H.a | McDonald, Robert J.a
Affiliations: [a] Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, Alberta, Canada | [b] Memorial University of Newfoundland, St. John’s, Newfoundland, Canada
Correspondence: [*] Correspondence to: Scott H. Deibel, Memorial University of Newfoundland, 230 Elizabeth Ave, St. John’s, Newfoundland, A1C 5S7, Canada. Tel.: +1 709 864 8000; E-mail: [email protected].
Abstract: Circadian rhythm dysfunction is present in Alzheimer’s disease. Animal models of Alzheimer’s disease have been employed to investigate whether this dysfunction is a risk factor or symptom of the disease. The circadian phenotype in mouse models of Alzheimer’s disease is very disparate in terms of the degree and timing of the dysfunction. This is likely a result of some models elevating amyloid-β protein precursor instead of just the amyloid-β fragment present in human Alzheimer’s disease. We characterized activity rhythms in a novel knock-in mouse model (APPNL-G-F) of Alzheimer’s disease that elevates amyloid-β without overexpressing amyloid-β protein precursor. Despite increased rhythm amplitude, total activity, and a shortening of free-running period at 15 months of age, all other aspects of the activity rhythm were similar to controls from three to fifteen months of age. At two months of age, these mice were also able to entrain to a light-dark cycle with a period right on the edge of entrainment, which further suggests a healthy functioning circadian system. These data open the possibility that circadian rhythm disruptions in transgenic models of Alzheimer’s disease could be a result of these models having an artificial phenotype caused by overexpression of amyloid-β protein precursor.
Keywords: Alzheimer’s disease, APPNL-G-F mice, circadian rhythms, knock in, mouse models, transgenic
DOI: 10.3233/JAD-190102
Journal: Journal of Alzheimer's Disease, vol. 71, no. 1, pp. 213-225, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]